Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
Total Assets
Fusion Antibodies PLC
Total Assets Peer Comparison
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fusion Antibodies PLC
LSE:FAB
|
Total Assets
£2.1m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Total Assets
£777.1m
|
CAGR 3-Years
40%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Total Assets
£51.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Total Assets
£48.3m
|
CAGR 3-Years
29%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
Ergomed PLC
LSE:ERGO
|
Total Assets
£133.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Total Assets
£83.2m
|
CAGR 3-Years
20%
|
CAGR 5-Years
61%
|
CAGR 10-Years
43%
|
See Also
What is Fusion Antibodies PLC's Total Assets?
Total Assets
2.1m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Total Assets amounts to 2.1m GBP.
What is Fusion Antibodies PLC's Total Assets growth rate?
Total Assets CAGR 5Y
-20%
Over the last year, the Total Assets growth was -48%. The average annual Total Assets growth rates for Fusion Antibodies PLC have been -37% over the past three years , -20% over the past five years .